COURTNEY TADIC: Open Payments
NPI 1568041382 · GEORGETOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,709 in 66 payments from 17 companies in 2025. Trend: 2023 $104 · 2024 $769 · 2025 $1,709
Food & beverage: $1,709
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 6 | $291 |
| GlaxoSmithKline, LLC. | 11 | $290 |
| Novo Nordisk Inc | 10 | $245 |
| AstraZeneca Pharmaceuticals LP | 6 | $221 |
| ABBVIE INC. | 5 | $114 |
| Ardelyx, Inc. | 4 | $98 |
| Lilly USA, LLC | 5 | $95 |
| Dexcom, Inc. | 3 | $56 |
| Antares Pharma, Inc. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
Products named: Prolastin-C Liquid, AREXVY, TRELEGY ELLIPTA, FARXIGA, IBSRELA, AIRSUPRA, MOUNJARO, Ozempic.
Industry payments across KY — which companies pay providers there.
